These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18338827)

  • 1. Proteome analysis of ventral midbrain in MPTP-treated normal and L1cam transgenic mice.
    Diedrich M; Mao L; Bernreuther C; Zabel C; Nebrich G; Kleene R; Klose J
    Proteomics; 2008 Mar; 8(6):1266-75. PubMed ID: 18338827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between stem cells and the dysfunctional brain is facilitated by manipulating the niche: evidence from an adhesion molecule.
    Ourednik V; Ourednik J; Xu Y; Zhang Y; Lynch WP; Snyder EY; Schachner M
    Stem Cells; 2009 Nov; 27(11):2846-56. PubMed ID: 19785036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
    Tieu K; Perier C; Vila M; Caspersen C; Zhang HP; Teismann P; Jackson-Lewis V; Stern DM; Yan SD; Przedborski S
    Ann Neurol; 2004 Jul; 56(1):51-60. PubMed ID: 15236401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
    Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down-regulation of pAkt.
    Durgadoss L; Nidadavolu P; Valli RK; Saeed U; Mishra M; Seth P; Ravindranath V
    FASEB J; 2012 Apr; 26(4):1473-83. PubMed ID: 22198382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model.
    Jeon S; Kim YJ; Kim ST; Moon W; Chae Y; Kang M; Chung MY; Lee H; Hong MS; Chung JH; Joh TH; Lee H; Park HJ
    Proteomics; 2008 Nov; 8(22):4822-32. PubMed ID: 18942673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in the differentiation-related molecular expression in the subventricular zone in a mouse model of Parkinson's disease.
    Oizumi H; Hayashita-Kinoh H; Hayakawa H; Arai H; Furuya T; Ren YR; Yasuda T; Seki T; Mizuno Y; Mochizuki H
    Neurosci Res; 2008 Jan; 60(1):15-21. PubMed ID: 17963913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
    Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
    Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
    Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F
    J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive acetylcholinesterase splicing patterns attenuate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Ben-Shaul Y; Benmoyal-Segal L; Ben-Ari S; Bergman H; Soreq H
    Eur J Neurosci; 2006 Jun; 23(11):2915-22. PubMed ID: 16819980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment.
    Liu M; Hunter R; Nguyen XV; Kim HC; Bing G
    J Neurosci Res; 2008 Sep; 86(12):2792-801. PubMed ID: 18500758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP.
    Samantaray S; Knaryan VH; Butler JT; Ray SK; Banik NL
    J Neurochem; 2008 Mar; 104(5):1309-20. PubMed ID: 18036149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
    Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T
    Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of gene expression profiles in the cervical spinal cord by acupuncture in an MPTP-intoxicated mouse model: microarray analysis.
    Choi YG; Yeo S; Hong YM; Kim SH; Lim S
    Gene; 2011 Jul; 481(1):7-16. PubMed ID: 21440609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E; Yano R; Yokoyama H; Kato H; Araki T
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.
    Jiang H; Li LJ; Wang J; Xie JX
    Exp Neurol; 2008 Aug; 212(2):532-7. PubMed ID: 18577498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease.
    Kurkowska-Jastrzebska I; Bałkowiec-Iskra E; Ciesielska A; Joniec I; Cudna A; Zaremba MM; Członkowski A; Członkowska A
    Int Immunopharmacol; 2009 Jun; 9(6):781-91. PubMed ID: 19286483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile.
    Cheng Y; He G; Mu X; Zhang T; Li X; Hu J; Xu B; Du G
    Neurosci Lett; 2008 Aug; 441(1):16-20. PubMed ID: 18586394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.
    Luchtman DW; Shao D; Song C
    Physiol Behav; 2009 Aug; 98(1-2):130-8. PubMed ID: 19410592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.